Skip to main content
. 2017 Apr 13;12:3049–3058. doi: 10.2147/IJN.S131805

Table 1.

Comparison of test results of the proposed label-free electrochemical immunosensor with ECL

Samples Found by the immunosensor (U/mL) Found by the ECL (U/mL) Relative error (%)
Normal control
 1 2.39 2.44 −2.05
 2 5.15 5.47 −5.85
 3 9.84 9.49 3.69
 4 9.25 10 −7.50
 5 13 13.95 −6.81
 6 17.71 18.59 −4.73
 7 18.75 19.58 −4.24
 8 20.72 22.48 −7.83
 9 25.86 24 7.75
 10 25.92 25.99 −0.27
Pancreatic cancer
 11 36.11 39.2 −7.88
 12 37.97 40.3 −5.78
 13 45.73 48.5 −5.71
 14 51.38 56 −8.25
 15 65.94 62.3 5.84
 16 64.86 63.5 2.14
 17 71.55 70.4 1.63
 18 81.26 73.5 10.56
 19 75.82 76 −0.24
 20 83.85 80.3 4.42
 21 90.05 88.3 1.98
 22 88.26 96.2 −8.25
 23 131.3 124.5 5.46
 24 144.5 150.8 −4.18
 25 189.1 198 −4.49
 26 198.9 219 −9.18
 27 213.9 227.8 −6.10
 28 289.8 276 5.00
 29 345.3 360 −4.08
 30 464.3 450 3.18

Abbreviation: ECL, electrochemiluminescence.